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1. Introduction
Gastrointestinal complications (GIC) in cardio-thoracic surgery (GIC-CTS) constitute a het‐
erogenous group of non-cardiac/thoracic complications. Although relatively infrequent,
these complications are associated with significant mortality and severe clinical sequelae. It
is also well recognized that GIC-CTS are often difficult to identify clinically [1], and the pre‐
sentation of each specific complication may differ from the presentation of said complication
in non-CTS patient populations. The incidence of gastrointestinal complications following
CTS ranges from <1% to 4.1% patients [2-4], and is associated with mortality rates between
13.9% and 63% [5-7]. Commonly reported GIC-CTS include gastrointestinal hemorrhage,
esophagitis/gastritis, perforated ulcer, acute cholecystitis, acute pancreatitis, and mesenteric
ischemia [5]. Predominant factors associated with increased mortality following a gastroin‐
testinal complication after cardiac surgery include patient age, COPD, smoking, NYHA class
III and IV heart failure, and hepatic insufficiency [8].
2. Risk factors for GIC-CTS
Numerous studies report on specific risk factors for GIC-CTS. Although some of the factors
seem to be universally present across different studies, some others are likely unique to spe‐
cific study populations. A comprehensive list of commonly cited risk factors compiled from
the literature includes: (a) decreased left ventricular ejection fraction (<40%) including post‐
operative low cardiac output; (b) advanced patient age; (c) pre-existing conditions such as
diabetes, renal failure, peripheral vascular disease; (d) valvular surgery or combined coro‐
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nary artery bypass/valve operation; (e) prolonged mechanical ventilation; (f) emergency sur‐
gery; (g) prolonged pump time; (h) need for intra-aortic balloon pump (IABP) or
vasopressors during or after surgery; (i) need for re-exploration following surgery (re-ster‐
notomy or re-thoracotomy); (j) pre-existing gastric ulcer disease; (k) stroke; and (l) postoper‐
ative sepsis/infectious complications including sternal wound infection [3-5, 9-12].
3. Physiologic and bowel motility changes following cardiac surgery
Despite significant hemodynamic implications of cardiac surgery, the effects on gastrointes‐
tinal system function are only modest at best. It is important to note that cardiopulmonary
bypass impairs small intestinal transport and increases gut permeability, especially when
pump times exceed 100 minutes [13]. Intestinal absorption also appears to be affected in car‐
dio-thoracic surgical patients [14].
Figure 1. Postoperative ileus following thoracoscopic right upper lobe resection. The patient improved markedly fol‐
lowing 5 days of therapy consisting of nasogastric suction, electrolyte correction and bowel rest.
The incidence of ileus (Figure 1) in cardio-thoracic surgical patients is between 1-2% [15].
Ileus is among the more common complications following cardio-thoracic procedures [16].
Various forms of ileus following CTS constitute approximately 10% of GIC [4]. Gastrointesti‐
nal motility dysfunction following cardio-thoracic procedures can take a number of clinical
manifestations, from isolated gastric distention to prolonged bowel dysfunction [9]. It is im‐
portant to note that the appearance of clinically significant new ileus, especially when ac‐
companied by severe abdominal pain, may indicate a more serious underlying problem
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such as mesenteric ischemia or pancreatitis [15]. Mandatory perioperative fasting, the effect
of anesthetic agents, and decreased patient mobility during immediate postoperative recov‐
ery, all contribute to temporary intestinal dysfunction, which in the vast majority of cases
regresses automatically after the initiation of enteral intake. In a small proportion of patients
the ileus persists past the fourth postoperative day, requiring the use of suppositories, ene‐
mas, and pro-motility agents (i.e., metaclopramide, erythromycin) to facilitate clinical reso‐
lution [17, 18]. In addition, the use of opioids has to be minimized due to the inhibitory
effect of these analgesic agents on bowel motility [19]. The abovementioned measures, in
conjunction with close clinical monitoring and normalization of serum electrolyte concentra‐
tions, are usually successful in restoring or improving intestinal function [20]. Cases that re‐
main unresponsive are treated with a course of nasogastric suction, which should be
continued until the return of bowel function.
4. Colonic pseudo-obstruction
Colonic pseudo-obstruction is a rare, poorly understood surgical complication with multifac‐
torial origins [21]. Characterized by marked colonic distention in the absence of distal obstruc‐
tion (Figure 2), this condition seems to be associated with the disturbance of the autonomic
innervation of the colon [22]. Untreated, colonic pseudo-obstruction leads to cecal over-disten‐
tion and subsequent perforation, with reported mortality as high as 15-50% [21, 22]. The critical
cecal diameter range at which perforation is more likely to occur is between 9-12 centimeters
[23]. The two main management modalities for colonic pseudo-obstruction, used alone or in
combination, are neostigmine administration and colonoscopic decompression [22, 24]. De‐
pending on whether indicated by the finding of bowel perforation or repeated episodes of
pseudo-obstruction, surgical options vary from cecal decompression (i.e., cecostomy) to colon‐
ic resection with entero-enterostomy or ostomy creation [25]. In the presence of sepsis with he‐
modynamic instability, damage control surgery may be justified [26-28].
5. Dysphagia
Dysphagia is a common complaint following cardio-thoracic operations [29]. Undoubtedly,
there is an association between history of endotracheal intubation, median sternotomy or
thoracotomy incisions, postoperative inflammatory changes in the chest/mediastinum and
dysphagia in the CTS patient population. The etiology of postoperative dysphagia is multi‐
factorial, including contributions from gastroesophageal reflux, local tissue trauma from
surgery and endotracheal intubation, intraoperative trans-esophageal echocardiography
(TEE), and other potential factors such as recurrent/superior laryngeal nerve dysfunction or
injury [30]. One of the more interesting contributors to post-CTS dysphagia is the perform‐
ance of intraoperative TEE, with nearly 8 times greater odds of developing dysphagia
among patients who underwent TEE versus those who did not [31].
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Figure 2. Colonic pseudo-obstruction following cardiac surgery. The first patient (left) presented with increasing ab‐
dominal pain/distention, nausea and vomiting following mitral valve replacement. Abdominal CT showed massively
dilated left colon with compressive effect on the surrounding small bowel. The pseudo-obstruction resolved with neo‐
stigmine therapy. The second patient (right) developed diffuse colonic dilatation following coronary artery bypass
grafting. His pseudo-obstruction resolved promptly following emergent colonoscopic decompression.
6. Gastritis and esophagitis
Gastritis and esophagitis are among the more commonly seen gastrointestinal complications
in the CTS patient population [32]. In addition to clinical symptoms and history, endoscopy
is the most commonly utilized diagnostic modality [33, 34]. Although esophagitis is often as‐
sociated with gastro-esophageal reflux (GER), the most pressing concern for post-CTS pa‐
tients with GER is the potential for pulmonary aspiration and associated complications [35].
The etiology of gastritis is multi-factorial, with major contributing elements including mu‐
cosal hypoperfusion, previous history of gastric mucosal disorder, and the use of non-steroi‐
dal anti-inflammatory drugs [36, 37]. Management includes avoidance of hypotension and
hypoperfusion, and aggressive management with H2-receptor blockers or proton pump in‐
hibitors. For postoperative patients with GER and high pulmonary aspiration risk, the main‐
tenance of 45 degree head-of-bed elevation is an important preventive measure [38].
7. Gastrointestinal hemorrhage
Gastrointestinal bleeding is among the most common GIC following cardio-thoracic proce‐
dures. In one study, gastrointestinal bleeding constituted nearly 29% of all GIC-CTS [32]. In
general, upper gastrointestinal bleeding occurs more frequently than lower gastrointestinal
bleeding, with most hemorrhages (>90%) occurring proximal to the ligament of Treitz [5].
Patients with previous history of peptic ulcer disease may be at higher risk for developing
an upper gastrointestinal perforation or hemorrhage following cardiac surgery, although
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other traditional risk factors such as H. pylori infection alone do not seem contributory [39].
Prolonged mechanical ventilation significantly elevates the risk of upper gastrointestinal
bleeding [39]. The two most common etiologies of upper gastrointestinal bleeding are duo‐
denal ulceration and gastric erosion. The appearance of gastric erosions following CTS is
likely secondary to systemic hypoperfusion with subsequent development of mucosal ische‐
mia and erosion [40].
The initial step in diagnosis of gastrointestinal bleeding is the placement of a nasogastric
(NG) tube and lavage of gastric contents. This aids in determining if the gastrointestinal
hemorrhage is proximal to the ligament of Treitz. Medical therapy is attempted first, and in‐
cludes the administration of H2-receptor blockers or proton pump inhibitors, red blood cell
transfusion, correction of coagulopathy, and temporarily withholding anticoagulation when
applicable/possible [41, 42]. If medical management fails, upper endoscopy is the next step
in evaluation and treatment of potential bleeding source(s) [43]. Endoscopic attempts aimed
at stopping the bleeding by cauterization, vasoconstrictive agent injection, or both are usual‐
ly effective [42, 43]. In one report, approximately half of the patient with upper gastrointesti‐
nal bleeding required upper endoscopy with cauterization to stop the hemorrhage while the
other half required surgical intervention to control the bleed [32]. Early surgical intervention
if patient fails medical and endoscopic treatment or if significant rebleeding occurs, is rec‐
ommended. In general, the presence of continued hemodynamic instability, or a pre-deter‐
mined transfusion threshold (i.e., >4-6 units of packed red blood cells) are utilized as
“surgical triggers”. Mortality related to gastrointestinal bleeding, even when requiring an
operation has decreased over the past two decades.
Lower gastrointestinal bleeding following cardio-thoracic procedures is usually approached
according to established clinical algorithms [44]. The first step in management is hemody‐
namic resuscitation and normalization of coagulation parameters. The bleeding usually
stops following these initial maneuvers. If the bleeding does not stop, the next step is the
identification of the source of hemorrhage, either endoscopically [45] or by imaging (nuclear
scan versus angiography) [46, 47]. In many cases, the bleeding can be controlled endoscopi‐
cally [48, 49]. Select cases can be treated with endovascular embolization [47]. Surgery
should be reserved for refractory cases, with the major determinants for surgery being the
failure of non-operative therapies, hemodynamic instability and/or the requirement for
transfusion (usually 4-6 units of packed red blood cells) [48, 49].
8. Mesenteric ischemia
Mesenteric ischemia (Figure 3) is a well known complication of CTS that usually occurs
within hours to several days after surgery. The gastrointestinal tract is vulnerable to ische‐
mia because it is often unable to acutely compensate for systemic hypotension. Further, due
to the potential for persistent vasoconstriction following the initial “low flow” state, gastro‐
intestinal ischemia may continue despite return of hemodynamic stability (i.e., non-occlu‐
sive mesenteric ischemia or NOMI). Intestinal ischemia may lead to complications such as
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mucosal sloughing, gangrenous changes of the bowel wall, and perforation. Mortality may
exceed 65% for patients with acute mesenteric ischemia [8]. Early recognition of signs and
symptoms of bowel ischemia and early intervention are integral to successful outcomes and
lower mortality rates [50]. One of the earliest signs of mesenteric ischemia is abdominal pain
out of proportion to physical examination findings [51]. However, this can be quite difficult
to elicit in postoperative CTS patients as many are mechanically ventilated and sedated fol‐
lowing surgery. In the setting of high clinical suspicion, sigmoidoscopy or colonoscopy can
aid in diagnosis of colonic ischemia [52]. The subsequent sections will discuss post-CTS mes‐
enteric ischemia as divided into two major pathophysiologic types: (a) “low flow state” sec‐
ondary to systemic hypoperfusion; or (b) thrombo-embolic events.
Figure 3. Abdominal CT scan of a patient who developed peritonitis several days after undergoing coronary artery
bypass grafting. The study shows diffuse portal venous gas (left) and pneumatosis of the bowel and the mesentery
(right). The patient underwent laparotomy with segmental resection of necrotic small bowel. A planned "second-look"
laparotomy showed no further bowel necrosis and primary small bowel anastomosis was performed.
9. Ischemia secondary to low flow state
Patients with poor cardiac functional status are at risk for splanchnic hypoperfusion secon‐
dary to a number of pre-operative (i.e., pre-existing mesenteric arterial disease), intra-opera‐
tive (i.e., hypotension/tissue hypoperfusion), and post-operative (i.e., low cardiac output)
risk factors. Preoperative presence of conditions such as low left ventricular ejection fraction
and peripheral vascular disease have been shown to be significant risks for developing post‐
operative gastrointestinal ischemia [32].
Intraoperatively, hypovolemia and use of vasoconstrictors can contribute to splanchnic hypo‐
perfusion [53]. Additionally, patients requiring longer cardiopulmonary bypass times may be
at greater risk for developing intestinal hypoperfusion [53]. This may be due to the non-pulsa‐
tile cardiopulmonary bypass flow characteristics, in conjunction with other factors such as the
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associated hemolysis, inflammatory cascade activation, the use of anticoagulation, the pres‐
ence of hypothermia, and the reduced end-organ perfusion. Further, cardiopulmonary bypass
may be associated with increased gastrointestinal permeability and enhanced cytokine release,
contributing to microcirculatory dysfunction and mucosal injury [32].
In the postoperative setting, inadequate blood flow to the intestines and subsequent intesti‐
nal ischemia/infarction can be associated with hypotension and/or cardiogenic shock [10]. In
one study, patients with renal failure (Creatinine >1.4), prior myocardial infarction, and
those requiring intra-aortic balloon pump support were at higher risk of developing mesen‐
teric ischemia secondary to “low flow” state [8]. Prolonged mechanical ventilation requiring
high positive end-expiratory pressure (PEEP) can also result in hypotension and impaired
cardiac output, leading to splanchnic vasoconstriction and hypoperfusion. Furthermore,
high PEEP is associated with activation of the renin-angiotensin-aldosterone system and in‐
creases in catecholamine levels [54]. This, in turn, results in shunting of blood away from the
gastrointestinal system, leading to mismatch between oxygen delivery and demand. Persis‐
tent deficit in oxygen delivery then leads to mucosal ischemia and damage. Moreover, dur‐
ing the process of tissue re-perfusion after restoration/normalization of adequate oxygen
delivery, the persistent vasoconstrictive state of non-occlusive mesenteric ischemia (NOMI)
may be seen [32]. Management of NOMI consists of restoration of adequate circulating intra‐
vascular volume, maintenance of adequate cardiac output, and selective angiographic ap‐
proaches utilizing intra-arterial vasodilating agent infusion therapy [55]. Surgery is reserved
for cases requiring resection of necrotic bowel, exploration for suspected perforation, and/or
revascularization procedure.
10. Embolic phenomena
Mesenteric ischemia following cardiac surgery results from embolic disease secondary to
macrovascular embolism or thrombosis, such as SMA embolus, or microvascular emboli,
such as embolic cholesterol “showering” secondary to aortic manipulation. Septic emboliza‐
tion with occlusive phenomena has also been reported in cases of endocarditis following
open heart surgery [56]. The size of the embolus may be an important prognostic factor. For
example, patients with large vessel emboli may have better outcomes when compared to pa‐
tients with microvascular or “distal” emboli [8]. High index of suspicion is critical to optimal
patient outcomes. If recognized promptly, occlusive emboli to the mesenteric circulation can
be treated via either endovascular and/or open surgical approaches, with acceptable success
rates [51]. Patients with hypotension, cardiogenic shock, and/or pump failure requiring in‐
tra-aortic balloon pump not only are at risk of significant intestinal hypoperfusion, but are
also at risk secondary to embolization and thrombus formation which may further exacer‐
bate the original insult to the intestinal tract. Surgical therapy is indicated if the patient de‐
velops peritonitis, perforation, sepsis, and/or end-organ failure in the setting of elevated
clinical suspicion [57]. Planned or "second look" surgery is warranted if ischemic (but non-
necrotic) bowel segments are noted at the conclusion of the initial procedure [58, 59]. Open
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abdominal approaches using temporary abdominal coverage with negative pressure wound
therapy have been described in such situations [27].
11. Pancreatitis
Acute pancreatitis is relatively uncommon (incidence 1-3%) following cardiopulmonary by‐
pass [15]. Clinically apparent pancreatitis usually occurs slightly later following cardiac sur‐
gery than other gastrointestinal complications, such as bleeding or mesenteric ischemia.
Patients typically complain of upper abdominal and left upper quadrant pain, nausea, vom‐
iting, and/or abdominal distension. Laboratory values including elevated amylase and li‐
pase are usually present. However, due to high incidence of hyperamylasemia in cardiac
surgery patients (>33%) [15], clinical correlation is required before definitive diagnosis of
pancreatitis is made.
The severity of pancreatitis ranges from subclinical (i.e., noted only on laboratory values) to
severe hemorrhagic, necrotic pancreatitis (seen in <0.5% of patients) (Figure 4) [60]. In one
study, nearly 20% of patients who underwent cardiac surgery were found to have evidence
of pancreatitis on autopsy [61]. Although the mechanism explaining the development of
pancreatitis after cardiac surgery has not been discovered, it has been hypothesized that low
flow state, tissue ischemia, gallstone disease, micro-embolization, and history of pre-existing
pancreatic disease all contribute to post-CTS acute pancreatitis.
 
 
 
 
 
 
 
Figure 4. Abdominal CT of a patient who developed acute upper abdominal pain following aortic valve replacement
surgery. Representative images of severe necrotizing pancreatitis are shown. Non-operative management resulted in
resolution of pancreatitis approximately 2 weeks after the diagnosis was made.
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12. Acute cholecystitis
Acute cholecystitis is another commonly seen gastrointestinal complication following CTS
(Figure 5). In one study, incidence of acute cholecystitis was approximately 8% among all
postoperative gastrointestinal complications [5]. Many cases of acute cholecystitis associated
with CTS are termed “acalculous cholecystitis” and are secondary to biliary stasis as a result
of multiple factors such as lack of enteral feeding and gallbladder wall ischemia secondary
to a “low flow” state. Mortality rates associated with acalculous cholecystitis are significant
(>50%) which may reflect the overall poor general health status of patients at risk for this
complication [62, 63]. Typical symptoms include right upper quadrant pain and tenderness
on examination. However, diagnosis is often delayed secondary to the presence of mechani‐
cal ventilation and sedation in significant proportion of patients with acalculous cholecysti‐
tis. Patients with acute cholecystitis, diagnosed most often on right upper quadrant
ultrasound or cholescintigraphy scan, require surgical intervention or percutaneous chole‐
cystostomy tube placement for treatment of cholecystitis. For poor surgical candidates, per‐
cutaneous cholecystostomy can serve as “bridging” therapy that facilitates the patient’s
recovery until he or she is ready to undergo cholecystectomy [64].
 
 
 
 
 
 
 
Figure 5. Elderly male patient developed cerebral infarction 2 days after undergoing aortic valve replacement. His re‐
covery was further complicated by acute cholecystitis, as demonstrated by right upper quadrant ultrasound showing
distended gallbladder with wall thickening, sludge and pericholecystic fluid (left). His operative risk for cholecystecto‐
my was prohibitive at that time, prompting the placement of percutaneous cholecystostomy (right). Following good
functional recovery and hospital discharge, the percutaneous drain was removed and the patient underwent elective
laparoscopic cholecystectomy.
13. Gastrointestinal complications unique to transplant recipients and
immunosuppression
Immunosuppressive regimens administered to transplant recipients predispose this patient
population to elevated risk for bacterial, fungal, parasitic, and viral infections [65]. Within
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this broad pathophysiologic spectrum, gastrointestinal infection and associated manifesta‐
tions feature prominently. While a complete discussion of this topic is beyond the scope of
this chapter, we thought it would be important to mention some of the more prominent
among these post-transplant sequelae. The list of potential gastrointestinal complications
seen after solid organ transplantation is diverse, including cytomegalovirus enteritis [65],
herpes simplex virus mucocutaneous manifestations [66], candidal esophagitis [67], Clostri‐
dium difficile and Yersinia enterocolitica infections [4], parasitic (protozoan/metazoan) enteritis
[67], and Helicobacter pylori infection [68]. Among other post-transplant gastrointestinal com‐
plications, organ recipients may be more likely to exhibit diarrhea, luminal ulcerations, per‐
forations, biliary tract complaints, pancreatitis, and gastrointestinal malignancy (i.e., post-
transplant lymphoproliferative disorder) [65, 69]. For more detail regarding post-transplant
and immunosuppresion-related gastrointestinal complications among heart and lung recipi‐
ents, the reader is referred to more specialized literature on this expansive topic [65, 67, 68].
14. Miscellaneous gastrointestinal and abdominal complications related
to cardiac surgery
Among less commonly encountered (and reported) complications of cardiac surgery are
those associated with trans-esophageal echocardiography (TEE). Likely under-reported,
TEE-related complications in cardiac surgical patients occur in as many as 1.2% of patients
[70]. In one series, esophageal and gastric tears were seen within 24 hours of the TEE in 2
patients, with additional gastric ulceration and gastric tear seen within 5 days of the proce‐
dure. Moreover, gastric perforations were described presenting between 4-11 days post-
TEE. Among the 6 reported cases, 3 required a laparotomy, 2 were treated endoscopically,
and 1 patient required transfusion [70].
Epigastric (sub-xiphoid) and chest tube site hernias [71] following cardiac surgery occur in as
many as 3-4% of patients following median sternotomy [72]. Another, much less common com‐
plications related to the mediastinal tube thoracostomy is superior epigastric artery pseudoa‐
neurysm [73]. Management of these rare conditions is mostly surgical, although minimally
symptomatic high-risk surgical patients may be followed with clinical observation.
Due to the growing volume of mechanical cardiac and pulmonary assistive technologies
(i.e., ventricular assist devices, intra-aortic balloon pumps, extra-corporeal membrane oxy‐
genation devices), it is important to mention potential gastrointestinal and abdominal com‐
plications associated with these devices. Not unexpectedly, the use of cardio-respiratory
mechanical assistive devices has been found to be associated with clinically significant ab‐
dominal and gastrointestinal complications [32, 74, 75]. For example, extracorporeal mem‐
brane oxygenation has been associated with embolic phenomena of the systemic circulation,
end-organ ischemia, gastrointestinal hemorrhage, and abdominal compartment syndrome
[74, 76-78]. Patients who undergo ventricular assist device placement are also exposed to a
number of potential gastrointestinal and abdominal complications, including abdominal in‐
fection, bowel injury, acalculous cholecystitis, pancreatitis, various hernias (i.e., incisional,
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inguinal, diaphragmatic), peritoneal fluid leaks, and mesenteric ischemia [75, 79-83]. Of
note, gastrointestinal hemorrhage has also been reported in patients with ventricular assist
devices [84, 85], with higher bleeding rates seen among recipients of non-pulsatile devices as
compared to pulsatile devices [86]. There is a trend toward higher mortality among patients
receiving ventricular assist devices who experience abdominal complications [75]. Intra-
aortic balloon pumps are among known risk factors for gastrointestinal complications fol‐
lowing CTS [8, 32]. Some of the reported GIC associated with intra-aortic balloon pump use
include gastrointestinal bleeding, bowel ischemia, and pancreatitis [78, 87, 88].
15. Conclusions
Gastrointestinal complications following cardio-thoracic procedures continue to significant‐
ly contribute to morbidity and mortality in this patient population. Preventive strategies,
coupled with early recognition and aggressive management of GIC-CTS constitute the foun‐
dation of the general clinical approach to these complications. Therefore, it is imperative
that all practitioners who care for postoperative cardiac and thoracic surgical patients are fa‐
miliar with the full spectrum of potential gastrointestinal complications in this patient popu‐
lation, as well as with general therapeutic approaches to these complications.
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